Drug discovery: selecting the optimal approach

Drug Discovery Today
Frank Sams-Dodd

Abstract

The target-based drug discovery approach has for the past 10-15 years been the dominating drug discovery paradigm. However, within the past few years, the commercial value of novel targets in licensing deals has fallen dramatically, reflecting that the probability of reaching a clinical drug candidate for a novel target is very low. This has naturally led to questions regarding the success of target-based drug discovery and, more importantly, a search for alternatives. This paper evaluates the strengths and limitations of the main drug discovery approaches, and proposes a novel approach that could offer advantages for the identification of disease-modifying treatments.

References

Feb 22, 2002·The New England Journal of Medicine·Susan Z Yanovski, Jack A Yanovski
May 10, 2002·The American Journal of Pathology·Mark S FormanJohn Q Trojanowski
Aug 28, 2002·Biochemical Society Transactions·N DanieleP R Shepherd
Jan 29, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Meera VaswaniSubramanyam Ramesh
Apr 8, 2003·Current Pharmaceutical Design·Murielle M Veniant, Carl P LeBel
Dec 25, 2003·Drug Discovery Today·David Brown, Giulio Superti-Furga
Jun 9, 2004·Drug Discovery Today·Gareth P Williams
Jul 22, 2004·Expert Opinion on Pharmacotherapy·Mark T Dransfield, William C Bailey
Oct 8, 2004·Nature Biotechnology·Eugene C ButcherEric J Kunkel
Dec 15, 2004·Archives of Neurology·Huw R MorrisJordi Perez-Tur
Feb 19, 2005·Drug Discovery Today·Frank Sams-Dodd
Feb 26, 2005·Science·Gorazd B StokinLawrence S B Goldstein
Apr 2, 2005·Nature Reviews. Immunology·David M Langenau, Leonard I Zon
May 26, 2005·Nature Reviews. Drug Discovery·Eugene C Butcher
Aug 2, 2005·Drug Discovery Today·Frank Sams-Dodd
Aug 17, 2005·Combinatorial Chemistry & High Throughput Screening·Charlotta GrånäsLen Pagliaro
Dec 25, 2009·Rinshō shinkeigaku = Clinical neurology·Katsuya Urakami, Miyoko Taniguchi

❮ Previous
Next ❯

Citations

Jun 20, 2007·Nature Chemical Biology·Barbara M SchmidtIlya Raskin
Oct 1, 2013·Bioinformatics·Kai-Cheng Hsu, Feng-Sheng Wang
Mar 22, 2014·Future Medicinal Chemistry·John G CummingMichael J Waring
Mar 2, 2012·Médecine sciences : M/S·Jacques HaiechMarie-Claude Kilhoffer
Mar 22, 2007·Expert Opinion on Therapeutic Targets·Andrea Brambilla, Paola Tarroni
Aug 22, 2015·Expert Opinion on Drug Discovery·Mirjam KeßlerSteffen Just
Mar 25, 2010·Expert Opinion on Drug Discovery·Robert Powers
Jan 31, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·V O ZambelliY Cury
Sep 28, 2010·Heart Failure Clinics·Daniel J Penny, Giles Wesley Vick
Nov 6, 2008·Drug Discovery Today·Jongin HongAndrew J deMello
Aug 5, 2008·Drug Discovery Today·Suzanne Sirois, L Martin Cloutier
Feb 6, 2007·Drug Discovery Today·Joost C M Uitdehaag
Jul 4, 2015·Arthritis & Rheumatology·Paola Mina-Osorio
Mar 21, 2015·Stem Cells and Development·Joshua G HunsbergerMahendra Rao
Jun 24, 2016·Journal of Cardiovascular Development and Disease·Daniel R BrownJiandong Liu
May 6, 2016·Expert Opinion on Drug Discovery·Dimitar Dobchev, Mati Karelson
Aug 7, 2007·Orphanet Journal of Rare Diseases·Laurnet Ségalat
Mar 7, 2012·Journal of Biomolecular Screening·Quinn LuSara H Thrall
Oct 15, 2019·Combinatorial Chemistry & High Throughput Screening·Cauê B Scarim, Chung M Chin
Jun 9, 2017·Journal of Inherited Metabolic Disease·F BellomoF Emma
Sep 23, 2020·Pharmacology & Therapeutics·Li ZhangGuanhua Du
Jun 6, 2009·Journal of Medicinal Chemistry·Jeffrey T BagdanoffDavid J Augeri

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.